View as Webpage


SPARTAN News—Fall 2022

Volume 8 Issue 3

Spondyloarthritis at ACR Convergence 2022

Here is a summary of the sessions at ACR Convergence

related to spondyloarthritis. Download schedule.


We are pleased to inform the SPARTAN membership and our partners in industry that we have completed recruitment of 501 patients to the CLASSIC study with database lock on October 5. We have initiated our first analyses aimed at describing the study cohort. We are also working with ASAS on the primary objective of the study to determine whether the current ASAS classification criteria meet pre-specified performance targets, and if not how we might improve on the current criteria.



After a call for member applications to fill the roles of study PI and Steering Committee members, the SPARTAN Board of Directors appointed Drs. Kristi Kuhn (PI), Sibel Aydin, Atul Deodhar, and Judy Smith to the Steering Committee for BASIS. The group is finalizing the study protocol details, a request for proposals by contract research organizations to help manage the study, as well as scopes of work for the CRO and biorepository. Once proposals have been received, the Steering Committee will review and make recommendations to the Board for final approval. These steps will allow the Steering Committee to finalize budget projections and begin soliciting funding for BASIS.

EIDA, a project to educate non-rheumatologists about clinical features that suggest the presence of axial spondyloarthritis (axSpA) and to prompt rheumatology referrals has been extended through 2023. Grand Rounds and meeting presentations will continue through the US and Canada to PCP, chiropractor, PA, physiatrist, and physiotherapy groups.

The successful CAPES (Clinician and Patient Education Series) collaboration with GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), NPF (National Psoriasis Foundation), SAA (Spondylitis Association of America), concluded on November 3 with on-demand viewing of CME videos and access to the podcasts available on our website.

Membership update

The SPARTAN Governance Committee has

approved the following membership changes

Trainee to Associate Membership:

Daniel Kuo, Linh Truong

Associate to Full Membership:

Mohamad Bittar, Elizabeth Chang, Soha Dolatabadi, Meika Fang, Anand Kumthekar, Fardina Malik, Ruth Napier

Join us on LinkedIn and Follow us on Twitter!

LinkedIn  Twitter

RFI on NIAMS Strategic Plan

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS is updating its Strategic Plan to help guide the research it supports over the next 5 years. NIAMS invites feedback from researchers in academia and industry, health care professionals, scientific or professional organizations, and other interested members of the public.

Read more here.

Save the Dates

Thank you for the Support of our Industry Partners

SPARTAN Sponsors: Abbvie, Janssen, Lilly, UCB, Novartis, Pfizer

SPARTAN is a network of health care professionals in North America who are dedicated to research, awareness and treatment of spondyloarthritis. SPARTAN is funded through educational grants from companies with an interest in this area of medicine.

Twitter  LinkedIn